3,4-Dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide

Catalog No.: 
ACRELC901
CAS No.: 
1799973-91-3
Molecular Formula: 
C8H9NO3S
Molecular Weight: 
199.23
3,4-Dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$92.00In stockInquiry
250mg97%$158.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,4-Dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide
IUPAC Name3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide
MDL No.MFCD28969714
Molecular FormulaC8H9NO3S
Molecular Weight199.23
SMILESO=S1(C2=CC=CC=C2OCCN1)=O
InChI KeyOMLZQCAXQZDRQH-UHFFFAOYSA-N
Synonym3,4-Dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide;133028;3,4-dihydro-2h-5,1lambda6,2-benzoxathiazepine-1,1-dione;2H-5,1,2-Benzoxathiazepine, 3,4-dihydro-, 1,1-dioxide
CAS No.1799973-91-3
PubChem CID69470608

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRELC901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRELC901 route product structure diagram
    ACRELC9011799973-91-3In Stock
Inquiry

2. ACRELC901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRELC901 route product structure diagram
    ACRELC9011799973-91-3In Stock
Inquiry

3. ACRELC901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRELC901 route product structure diagram
    ACRELC9011799973-91-3In Stock
Inquiry

Comments (0)